Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17470817 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects
Condition: Schizophrenia
Interventions: Device: AVL-3288;   Drug: Placebo

Indicates status has not been verified in more than two years